title: [Chemotherapy in elderly patients with hematological malignancies].
abstract: A half of patients with acute myeloid leukemia and lymphoma are older than 60 years. However, using chronological age for estimating chemotherapy-related risks is unreliable, and patients without comorbidity may be candidates for the standard therapy. For patients who have complex comorbidity or are older than 75 years, a reduced dose of chemotherapy or palliative treatment is appropriate. Molecular targeted therapy may be tolerable for elderly patients.
authors: Hamamatsu University, Oncology Center, Hamamatsu, Japan.
authors: Kazunori
authors: K
authors: Ohnishi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019337:Hematologic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D058990:Molecular Targeted Therapy; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents